OmniStocks (@LetsGoSTX) header
OmniStocks (@LetsGoSTX) profile picture

We are all on the same team. Letโ€™s make it big! Tweets and thoughts are my own, do your own research, make your own choices!

New York, USA
Joined October 2021
Photo by OmniStocks (@LetsGoSTX)Photo by OmniStocks (@LetsGoSTX)Photo by OmniStocks (@LetsGoSTX)Photo by OmniStocks (@LetsGoSTX)Photo by OmniStocks (@LetsGoSTX)Photo by OmniStocks (@LetsGoSTX)Photo by OmniStocks (@LetsGoSTX)Photo by OmniStocks (@LetsGoSTX)Photo by OmniStocks (@LetsGoSTX)Photo by OmniStocks (@LetsGoSTX)
$NSAV is only the 2nd publicly traded US Cex๐Ÿ’ฅ So, You can buy $COIN at > $200 per share or $NSAV for < 2 cents per share๐Ÿ’ฅ Q1 Fins = Revenue of $204 MM ๐Ÿ™Œ #NSAV is FINCEN registered w/#FIAT on-ramp/off-ramp capabilities! #BULL Run $AMC $GME $FFIE Kroos #OTC
1
16
1
27
1,641
#NSAV the leader in the otc now! $204,000,000 revenues!
8
2
29
766
Replying to @DonHollywood22
We need to do better with shareholder engagement and communicating the value of our scientific milestones and their impact on disease diagnosis, treatment, and potential cure. This will change now. We are grateful for your continued faith and support. Onwards and Upwards
46
39
16
254
36,005
Stocks Under 5ยข To Watch Now! $HNRC, $HALB, $ENZC, $SNNC, $SPZI thestreetreports.com/stocks-โ€ฆ
2
2
1
10
4,040
Replying to @Bradyshonor
Yes, we continue to advance on the planned milestones. The required steps for SPAC are in process and an update on partnerships and progress shall be provided through an official press release and filings in due course. We appreciate your continued faith and patience. #ENZC
26
42
15
237
39,148
OmniStocks retweeted
Sagaliam Acquisition Corp. Class A Common Stock (SAGA) SEC Filings | Nasdaq $ENZC nasdaq.com/market-activity/sโ€ฆ
6
21
812
#BGEN continues to make a significant impact in drug discovery and development by utilizing advanced AI technology. Our focus is on safeguarding our assets while expanding our IP portfolio to include #AI -driven monoclonal antibodies. With these antibodies, we aim to revolutionize the fight against #HIV , #COVID19 mutations, and other viruses. Collaborating with pharmaceutical companies, our focus is to cover all viruses in our repository, providing patients with necessary diagnostics and therapies. Our "AI Platform is constantly evolving with disruptive innovations" in healthcare. We are proud to be at the forefront of this crucial work and look forward to continuing to positively impact the world. #ENZC #NASDAQ nasdaq.com/press-release/enzโ€ฆ
18
68
25
340
61,190
Enzolytics, Inc. made a groundbreaking move by finalizing a binding business combination agreement with Sagaliam Acquisition Corp. This agreement involved the sale of two innovative companies, Biogenysis, Inc. and Virogentics Inc., in a remarkable transaction valued at a staggering $450,000,000. The future of this combined company looks promising as it is expected to trade on NASDAQ, showcasing its immense potential to investors and the market. You can find the full article in the link comments.
2
28
3
117
9,128
The Company has executed a binding business combination agreement for the purchase of #BGEN & VIRO, operating subsidiaries of Enzolytics Inc. #ENZC The combined company is expected to trade on NASDAQ. finance.yahoo.com/news/sagalโ€ฆ
17
59
13
209
27,880
Replying to @DavidM66626845
Excellent. I am pleased that the disruptive potential of this partnership has been realized. #BGEN
9
27
7
198
13,401
$ENZC For those needing constant reassurance on the Business Combination Agreement with $SAGA, the company reaffirms that the $450MM deal will be the basis for achieving these objectives. The deal should be consummated soon. My guess is this month. We're winning 2023 ๐Ÿ†
$ENZC ๐Ÿ—ž Press Release ๐Ÿ—ž ๐˜ฝ๐™ž๐™ค๐™œ๐™š๐™ฃ๐™ฎ๐™จ๐™ž๐™จ, ๐™„๐™ฃ๐™˜. ๐˜ผ๐™ฃ๐™ฃ๐™ค๐™ช๐™ฃ๐™˜๐™š๐™จ ๐™‹๐™–๐™ง๐™ฉ๐™ฃ๐™š๐™ง๐™ž๐™ฃ๐™œ ๐™ฌ๐™ž๐™ฉ๐™ ๐™†๐™๐™–๐™ก๐™ฅ๐™š๐™ฎ ๐˜ผ๐™„ ๐™‡๐™–๐™— ๐™–๐™ฃ๐™™ ๐˜พ๐™ค๐™ฃ๐™ฉ๐™š๐™ฃ๐™ฉ๐™–, ๐™‡๐™ฉ๐™™. ๐™ฉ๐™ค ๐™„๐™ฃ๐™˜๐™ค๐™ง๐™ฅ๐™ค๐™ง๐™–๐™ฉ๐™š ๐˜ผ๐™„ ๐™ž๐™ฃ ๐™ˆ๐™ž๐™˜๐™ง๐™ค๐™—๐™ž๐™ค๐™ข๐™š ๐˜ผ๐™ฃ๐™–๐™ก๐™ฎ๐™จ๐™ž๐™จ ๐™ฉ๐™ค ๐™„๐™™๐™š๐™ฃ๐™ฉ๐™ž๐™›๐™ฎ ๐˜ฝ๐™ž๐™ค๐™ข๐™–๐™ง๐™ ๐™š๐™ง๐™จ ๐™›๐™ค๐™ง ๐™๐™จ๐™š ๐™ž๐™ฃ ๐˜ผ๐™˜๐™˜๐™ช๐™ง๐™–๐™ฉ๐™š๐™ก๐™ฎ ๐™‹๐™ง๐™š๐™™๐™ž๐™˜๐™ฉ๐™ž๐™ฃ๐™œ ๐˜ผ๐™ก๐™ฏ๐™๐™š๐™ž๐™ข๐™š๐™ง'๐™จ ๐˜ฟ๐™ž๐™จ๐™š๐™–๐™จ๐™š ๐™Š๐™ฃ๐™จ๐™š๐™ฉ ๐™–๐™ฃ๐™™ ๐™‹๐™ง๐™š๐™ซ๐™š๐™ฃ๐™ฉ๐™ž๐™ค๐™ฃ. 1๏ธโƒฃ Biogenysis is at the forefront of applying AI to create new and improved health therapies. 2๏ธโƒฃ The structured partnership will combine the efforts and expertise of Biogenysis with those of Khalpey AI Lab and Contenta, Ltd. 3๏ธโƒฃ Collaborating with Contenta and Khalpey AI Lab will make possible analysis of the gut microbiota of thousands of patients to identify those at higher risk of developing dementia and permit the design of preventative treatments to avoid cognitive decline. 4๏ธโƒฃ The Company has 4 pending International Patent Applications claiming significant discoveries derived from application of its AI Platform to produce new and effective therapies. Many more developments are planned including the patenting of each๐Ÿ”ฅ 5๏ธโƒฃ Our partnering with Khalpey AI Lab and Contenta, Ltd. will accelerate the Company's objective to use AI to develop infectious disease therapeutics for improving health care around the world. This partnership and our planned business combination with Sagaliam Acquisition Corporation will provide the basis for achieving this objective ๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ otcmarkets.com/stock/ENZC/neโ€ฆ
4
25
2
131
10,041
The potential for analyzing gut-brain communication with Artificial Intelligence is truly immense. Working with Contenta(Estonia) and @ZainKhalpey AI Lab, we can identify those at higher risk of developing dementia. This can lead to the development of preventative treatments for #Alzheimer's disease and other neurodegenerative diseases.#AI #BGEN #Patent #portfolio finance.yahoo.com/news/biogeโ€ฆ @KhalpeyLab
18
58
6
281
23,347
OmniStocks retweeted
Replying to @enzolytics
@enzolytics @Virogentics is in #Africa right now starting their pilot clinical trial for #ITV1 to treat #HIV #GILD @GileadSciences itโ€™s time to team up and help the people living with this debilitating disease accesswire.com/774493/Gileadโ€ฆ #ENZC $ENZC #ENZO ๐Ÿฆฎ #SAGA $SAGA #VIRO #BGEN #SCIENCEWILLWIN #MilOneLion ๐Ÿฆ
5
1
16
1,834
Before sharing on social media, it's crucial to read our press releases and disclosures. Reading is essential for those who want to stand out, but choosing to remain "ordinary" is yours. #ENZC #BGEN
13
28
6
156
11,315
OmniStocks retweeted
๐Ÿš€ $ENZC - Exciting News! ๐ŸŒŸ Promising progress in HIV treatment! Virogentics' ITV-1 immunotherapy is shining in clinical trials. Stay tuned for life-changing updates! #HIVTreatment #ClinicalTrials #HealthcareInnovation tradersque.com/enzc-enzolytiโ€ฆ
2
32
1
85
9,548
Replying to @kshaughnessy2
Thank you for your continuous support. We remain humble and grounded with the ONLY focus on science and milestones. Onwards and upwards...#BGEN
8
21
4
169
6,983
Replying to @NatureMedicine
In light of the growing occurrence of #AntimicrobialResistance & the scarcity of viable remedies, it is absolutely crucial to explore new treatment options. One promising avenue involves focusing on the extensively conserved domains present in two-component systems (TCSs). #BGEN
4
20
5
163
10,657
$ENZC ๐Ÿ’ฅPRESS RELEASE๐Ÿ’ฅ 1๏ธโƒฃ Approval for the final protocol from Congos #HIV deparment, Ministry of Health 2๏ธโƒฃ Administring #ITV1 in HIV patients in August ๐Ÿ”ฅ 3๏ธโƒฃ Expecting an EMA update! 4๏ธโƒฃ African partners are Government Leaders & Healthcare Institutions accesswire.com/769863/Virogeโ€ฆ
8
59
14
253
46,403